Raltegravir Intensification in HIV-infected Patients
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with Raltegravir further
decreases HIV viral replication in HAART-suppressed, HIV-infected patients, potentially
improving immune response to antiretroviral therapy.